Advertisement

Topics

Companies Related to "Study of Recombinant Modified Process Hepatitis B Vaccine in Older Adults" [Most Relevant Company Matches] - Page: 2 RSS

00:03 EDT 26th March 2019 | BioPortfolio

Here are the most relevant search results for "Study of Recombinant Modified Process Hepatitis B Vaccine in Older Adults" found in our extensive corporate database of over 50,000 company records.

Showing "Study Recombinant Modified Process Hepatitis Vaccine Older Adults" Companies 26–50 of 3,200+

Relevant

Aduro BioTech

Aduro BioTech is a clinical-stage immunotherapy company developing novel and potent vaccines based on Listeria monocytogenes. The company has engineered two distinct Listeria vaccine platforms to be safe for use in humans while continuing to induce robust immune responses. These advances have been published in 20 major studies and have generated more than ...


Vaxine Pty Ltd

Established in 2002, Vaxine is an Australian-based biotechnology company specialising in vaccine development. Lead products in clinical trials include vaccines for seasonal and pandemic influenza (including 2009 H1N1 swine flu), Japanese encephalitis, hepatitis B, and bee sting allergy.

Affinivax, Inc.

Affinivax is advancing a next generation vaccine technology platform to enable the development of vaccines that provide the highest level of protection against challenging infectious diseases. Backed by an investment from the Bill & Melinda Gates Foundation, and working with world experts in vaccine discovery and development, Affinivax is focused on creati...


iQur Ltd

iQur® is a specialty pharmaceutical company at the forefront of international breakthroughs in the detection, treatment and monitoring of Hepatitis C and other liver diseases.iQur exists to provide clinicians with a comprehensive, 24–48 hour service for genotyping, qualitation and quantification of both the Hepatitis C (HCV) and Hepatitis B (HBV) viruses.Founded in 2003 by liver disease special...

Hometeam

Headquartered in New York and with offices in three states, Hometeam transforms the in-home care and aging experience by providing elderly clients with personalized care planning, expert caregiver matching, custom mobile technology, and proactive case management to improve older adults’ health and well-being while giving their families peace of mind. ...

RiboTask ApS

RiboTask is a RNA reagent and development company. The main focus is on the synthesis of LNA-modified RNA and LNA-modified 2’-O-Me-RNA. These products are ideal for knock down, as microRNA-probes (Superior-microRNA-probesTM), and incorporation of LNA in siRNA (siLNA) ensures high biostability and less off-target effect. RiboTask is also geared to the synthesis of highly complex RNA oligonucleot...

Genious Targeting Laboratory, Inc

Established in 1998, iTL is a contract research facility that produces genetically modified mice for global pharmaceutical, biotechnology and academic institutions. Compared to other target-identification technologies, genetically modified mice provide the most biologically relevant information about gene function. As cost containment pressures increase, iTL offers expertly executed, timesaving, a...

Eiger BioPharmaceuticals, Inc.

Eiger is focused on the discovery and development of new antiviral agents against novel targets for the treatment of hepatitis virus infections. Eiger's pipeline includes repurposed clinical stage therapeutic agents as well as preclinical NCEs from discovery that exhibit antiviral activity against Hepatitis C, Hepatitis D, and other viruses. Eiger investors include InterWest Partners www.interwest...

Biostar Pharmaceuticals, Inc.

Biostar Pharmaceuticals, Inc., through its wholly-owned subsidiary in China, develops, manufactures and markets pharmaceutical products for a variety of diseases and conditions. The Company's most popular product is its Xin-Aoxing Oleanolic Acid Capsule, an over-the-counter ("OTC") medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. In addition to...

Sabin Vaccine Institute

Sabin Vaccine Institute is a 501(c)(3) non-profit organization dedicated to reducing human suffering from infectious and neglected diseases. Through its efforts in vaccine research, development and advocacy, Sabin works to provide greater access to vaccines and essential medicines for millions mired in pain, poverty and despair. Founded in 1993 in honor of Dr. Albert B. Sabin, discoverer of the or...

Inviragen, Inc. and PharmaJet, Inc.

Inviragen is focused on developing vaccines to protect against infectious diseases worldwide. Inviragen's lead product candidate is a vaccine to protect against dengue fever. Inviragen is also developing vaccines to protect against hand, foot and mouth disease and Japanese encephalitis, both of which affect millions of children in Asia. Vaccines in preclin...

Hawaii Biotech, Inc.

Hawaii Biotech, Inc. is a privately held biopharmaceutical company focused on vaccine research and development. The company is targeting first world vaccines with potentially large markets and attractive margins: a West Nile vaccine targeting the U.S. and Canada; and a dengue fever vaccine for travelers from first world countries to dengue endemic areas. The Company’s vaccine technology was feat...

Profectus BioSciences, Inc.

Profectus BioSciences, Inc. is a technology based vaccine company devoted to the treatment and prevention of chronic viral diseases with a goal of reducing morbidity and mortality. Since its inception in 2003, the Company’s strategic intent has been to develop and acquire the technologies needed to deliver on that mission within high value mark...

Genetic Immunity, LLC

Genetic Immunity is a biopharmaceutical company focused on therapeutic vaccine development and commercialization. The lead product, DermaVir vaccine patch, is under clinical evaluation in Hungary and in the USA for the treatment for HIV/AIDS, where resistance, toxicity, adherence and cost limit the use of drugs. The Company’s vaccine composition mimics the successful induction of antiviral immun...

PharmaLinkFHI, Inc.

PharmaLink provides complete eClinical research services to support and streamline the drug development process. Clinical teams leverage real-time study information to make immediate decisions based on emerging trends and study issues. Our accelerated processes, centralized information management and global reach make it possible to conduct trials of any size or complexity from virtually anywhere....

ImmunoBiology Limited (ImmBio)

Limited [ImmBio] is a biotechnology company specialising in the treatment of infectious diseases and cancer. ImmBio's approach is to apply advances in the emerging science of Immunobiology to the development of treatments for infections diseases and cancer. Immbio is developing a proprietary vaccine technology based on these advances. The platform technology is called HspC™ vaccination. HspC...

International Medica Foundation

The International Medica Foundation, which has the rights to RotaShield, is a nonprofit foundation that focuses on ensuring that a safe, effective and affordable rotavirus vaccine is clinically tested and then can be provided to families in need globally. The International Medica Foundation also aims to ensure that the manufacturing process for Rota...

LivHOME, Inc.

LivHOME® is one of the nation's largest providers of professionally led at-home care for seniors. The company is dedicated to finding solutions that enable older adults to remain in their homes as long as possible. Based in Los Angeles, LivHOME® delivers high quality at-home care at company-owned locations throughout California as well as Arlington, ...

OSMOPHARM SA

Osmopharm is a Swiss pharmaceutical company specialised in modified oral drug delivery systems, based on the application of some of the more advanced galenic technologies.Osmopharm studies, develops and produces modified release forms under contract manufacturing. Therefore Osmopharm offers his costumers a global support: - R&D - technical files for registration- finished product in bulks, or dose...

Ondek Pty Ltd

Ondek was established in 2005 to develop and commercialise a novel drug and vaccine delivery platform based on the use of genetically modified Helicobacter pylori bacteria. We call this technology the Helicobacter pylori Platform Technology (HPPT), a revolutionary drug and vaccine delivery vehicle that has potential application across the spectrum of the pharmaceutical industry. Led by Nobel Priz...

Aging2.0

Aging2.0 (www.aging2.com) is a global organization on a mission to accelerate innovation to improve the lives of older adults around the world. Aging2.0 connects, educates and supports innovators through regular events, the CoverAGE newsletter and the GENerator founders program. Over the past 18 months, Aging2.0 has hosted 30 events in 10 cities across thr...

SciClone Pharmaceuticals

SciClone is a global biopharmaceutical company that acquires, develops, and commercializes specialist-oriented drugs for treating chronic and life-threatening diseases, such as hepatitis B, hepatitis C, cancer, immune system disorders and cystic fibrosis.

Tripep

Tripep develops drugs against chronic disease based on proprietary and other parties’ patented and patent pending technologies. Tripep is focusing on the following research projects; wound healing therapy ChronSeal® and a therapeutic vaccine against Hepatitis C, named ChronVac-C®, plus the RAS® technology platform. The Tripep share is admitte...

Biotech Synergy

Biotech Synergy has secured in San Diego the necessary competences to bring this promising multi epitope cancer vaccine to latest stage development. Contrary to Dendreon individualized vaccine, EP-2101 is made of 10 peptides and is an off the shelf readily available vaccine for the HLA-A2 population, which represents 45% of the global NSCLC patients (100,0...

Beltone

Founded in 1940, Chicago-based Beltone is part of the GN Hearing Care Group, utilizing advanced technology to produce hearing instruments sold in the United States, Canada and over 50 countries worldwide. In addition to providing outstanding service and support for its U.S. hearing care network operating in over 1,500 offices in North America, Beltone rema...


More From BioPortfolio on "Study of Recombinant Modified Process Hepatitis B Vaccine in Older Adults"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks